{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:54:46Z","timestamp":1791546886242,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-05339-5","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:55:02Z","timestamp":1788454502000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Urine dipstick test for assessing albumin-to-creatinine ratio: a pilot study and the potential impact on chronic kidney disease screening"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4393-7330","authenticated-orcid":false,"given":"Farid","family":"Samaan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0225-2521","authenticated-orcid":false,"given":"Cristiane Akemi","family":"Vicente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7450-9208","authenticated-orcid":false,"given":"Amilton","family":"Mouro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8929-1013","authenticated-orcid":false,"given":"Vit\u00f3ria \u00c2ngela Lorenzini Bellotto","family":"Bellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9143-1257","authenticated-orcid":false,"given":"Renata","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8565-5193","authenticated-orcid":false,"given":"Let\u00edcia","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2185-2150","authenticated-orcid":false,"given":"Carlos Augusto Lima","family":"de Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4203-3196","authenticated-orcid":false,"given":"Jos\u00e9 Arnaldo","family":"Shiomi Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1062-0073","authenticated-orcid":false,"given":"Ricardo","family":"Sesso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1317-4109","authenticated-orcid":false,"given":"Gianna","family":"Mastroianni-Kirsztajn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"issue":"10518","key":"5339_CR1","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1016\/S0140-6736(25)02363-3","volume":"406","author":"The Lancet","year":"2025","unstructured":"The Lancet. Chronic kidney disease: breaking the silence. Lancet. 2025;406(10518):2393. https:\/\/doi.org\/10.1016\/S0140-6736(25)02363-3.","journal-title":"Lancet"},{"issue":"1","key":"5339_CR2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12882-024-03466-5","volume":"25","author":"DR Farrell","year":"2024","unstructured":"Farrell DR, Vassalotti JA. Screening, identifying, and treating chronic kidney disease: why, who, when, how, and what? BMC Nephrol. 2024;25(1):34. https:\/\/doi.org\/10.1186\/s12882-024-03466-5.","journal-title":"BMC Nephrol"},{"key":"5339_CR3","unstructured":"Minist\u00e9rio, da Sa\u00fade. Brazil. Portaria conjunta SAES\/SECTICS n\u00ba 11, de 16 de setembro de 2024. Secretaria de Aten\u00e7\u00e3o Especializada \u00e0 Sa\u00fade. Secretaria de Ci\u00eancia, Tecnologia, Inova\u00e7\u00e3o e do Complexo Econ\u00f4mico-Industrial da Sa\u00fade. Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas das Estrat\u00e9gias para Atenuar a Progress\u00e3o da Doen\u00e7a Renal Cr\u00f4nica. Available from: https:\/\/www.gov.br\/saude\/pt-br\/assuntos\/pcdt\/e\/estrategias-para-atenuar-a-progressao-da-doenca-renal-cronica\/view."},{"issue":"4S","key":"5339_CR4","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4S):S117\u2013314. https:\/\/doi.org\/10.1016\/j.kint.2023.10.018.","journal-title":"Kidney Int"},{"issue":"5","key":"5339_CR5","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1053\/j.ajkd.2024.09.017","volume":"85","author":"NC Hodel","year":"2025","unstructured":"Hodel NC, Rentsch KM, Paris DH, Mayr M. Methods for Diagnosing Proteinuria-When to Use Which Test and Why: A Review. Am J Kidney Dis. 2025;85(5):618\u201328. https:\/\/doi.org\/10.1053\/j.ajkd.2024.09.017.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"5339_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.11622\/smedj.2015003","volume":"56","author":"KW Tang","year":"2015","unstructured":"Tang KW, Toh QC, Teo BW. Normalization of urinary biomarkers to creatinine for clinical practice and research\u2013when and why. Singap Med J. 2015;56(1):7\u201310. https:\/\/doi.org\/10.11622\/smedj.2015003.","journal-title":"Singap Med J"},{"issue":"5","key":"5339_CR7","doi-asserted-by":"publisher","first-page":"e307","DOI":"10.1016\/S2214-109X(16)00071-1","volume":"4","author":"B Ene-Iordache","year":"2016","unstructured":"Ene-Iordache B, Perico N, Bikbov B, Carminati S, Remuzzi A, et al. Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study. Lancet Glob Health. 2016;4(5):e307\u201319. https:\/\/doi.org\/10.1016\/S2214-109X(16)00071-1.","journal-title":"Lancet Glob Health"},{"key":"5339_CR8","unstructured":"Minist\u00e9rio da Sa\u00fade. Brazil. Ag\u00eancia Nacional de Sa\u00fade Suplementar. PROMOPREV - Programa de Promo\u00e7\u00e3o da Sa\u00fade e Preven\u00e7\u00e3o de Riscos e Doen\u00e7as. Available from: https:\/\/www.gov.br\/ans\/pt-br\/assuntos\/operadoras\/compromissos-e-interacoes-com-a-ans-1\/programas-ans-1\/promoprev."},{"issue":"1","key":"5339_CR9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.11613\/BM.2016.008","volume":"26","author":"RC Dolscheid-Pommerich","year":"2016","unstructured":"Dolscheid-Pommerich RC, Klarmann-Schulz U, Conrad R, Stoffel-Wagner B, Zur B. Evaluation of the appropriate time period between sampling and analyzing for automated urinalysis. Biochem Med (Zagreb). 2016;26(1):82\u20139. https:\/\/doi.org\/10.11613\/BM.2016.008.","journal-title":"Biochem Med (Zagreb)"},{"key":"5339_CR10","doi-asserted-by":"publisher","first-page":"h5527","DOI":"10.1136\/bmj.h5527","volume":"351","author":"PM Bossuyt","year":"2015","unstructured":"Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, STARD Group, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ. 2015;351:h5527. https:\/\/doi.org\/10.1136\/bmj.h5527.","journal-title":"BMJ"},{"key":"5339_CR11","unstructured":"Minist\u00e9rio da Sa\u00fade, Brazil. Secretaria de Vigil\u00e2ncia em Sa\u00fade e Ambiente. Departamento de An\u00e1lise Epidemiol\u00f3gica e Vigil\u00e2ncia de Doen\u00e7as N\u00e3o Transmiss\u00edveis. Vigitel Brasil 2023: vigil\u00e2ncia de fatores de risco e prote\u00e7\u00e3o para doen\u00e7as cr\u00f4nicas por inqu\u00e9rito telef\u00f4nico. Available from: http:\/\/bvsms.saude.gov.br\/bvs\/publicacoes\/vigitel_brasil_2023.pdf."},{"issue":"Suppl 6","key":"5339_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1093\/ndt\/10.supp6.6","volume":"10","author":"R Pontremoli","year":"1995","unstructured":"Pontremoli R, Cheli V, Sofia A, Tirotta A, Ravera M, et al. Prevalence of micro- and macroalbuminuria and their relationship with other cardiovascular risk factors in essential hypertension. Nephrol Dial Transpl. 1995;10(Suppl 6):6\u20139. https:\/\/doi.org\/10.1093\/ndt\/10.supp6.6.","journal-title":"Nephrol Dial Transpl"},{"key":"5339_CR13","doi-asserted-by":"publisher","unstructured":"Gall MA, Rossing P, Sk\u00f8tt P, Damsbo P, Vaag A, et al. Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 1991;34(9):655\u2009\u2013\u200961. https:\/\/doi.org\/10.1007\/BF00400995.","DOI":"10.1007\/BF00400995"},{"key":"5339_CR14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.amjcard.2021.12.023","volume":"168","author":"Y Suzuki","year":"2022","unstructured":"Suzuki Y, Kaneko H, Okada A, Itoh H, Fujiu K, et al. Risk for Proteinuria in Newly Defined Hypertensive People Based on the 2017 American College of Cardiology\/American Heart Association Blood Pressure Guideline. Am J Cardiol. 2022;168:83\u20139. https:\/\/doi.org\/10.1016\/j.amjcard.2021.12.023.","journal-title":"Am J Cardiol"},{"issue":"1","key":"5339_CR15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s12967-021-02934-y","volume":"19","author":"J Jeon","year":"2021","unstructured":"Jeon J, Kim J. Dipstick proteinuria and risk of type 2 diabetes mellitus: a nationwide population-based cohort study. J Transl Med. 2021;19(1):271. https:\/\/doi.org\/10.1186\/s12967-021-02934-y.","journal-title":"J Transl Med"},{"issue":"2","key":"5339_CR16","first-page":"89","volume":"32","author":"DW Johnson","year":"2011","unstructured":"Johnson DW. Global proteinuria guidelines: are we nearly there yet? Clin Biochem Rev. 2011;32(2):89\u201395. PMID: 21611082; PMCID: PMC3100286.","journal-title":"Clin Biochem Rev"},{"issue":"645","key":"5339_CR17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3399\/bjgp16X684721","volume":"66","author":"SD Fraser","year":"2016","unstructured":"Fraser SD, Roderick PJ, Taal MW. Where now for proteinuria testing in chronic kidney disease? Good evidence can clarify a potentially confusing message. Br J Gen Pract. 2016;66(645):215\u20137. https:\/\/doi.org\/10.3399\/bjgp16X684721.","journal-title":"Br J Gen Pract"},{"issue":"8","key":"5339_CR18","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.7150\/ijms.45470","volume":"17","author":"WY Su","year":"2020","unstructured":"Su WY, Wu PY, Huang JC, Chen SC, Chang JM. Increased Proteinuria is Associated with Increased Aortic Arch Calcification, Cardio-Thoracic Ratio, Rapid Renal Progression and Increased Overall and Cardiovascular Mortality in Chronic Kidney Disease. Int J Med Sci. 2020;17(8):1102\u201311. https:\/\/doi.org\/10.7150\/ijms.45470.","journal-title":"Int J Med Sci"},{"issue":"1","key":"5339_CR19","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.kint.2016.09.037","volume":"91","author":"JJ Carrero","year":"2017","unstructured":"Carrero JJ, Grams ME, Sang Y, \u00c4rnl\u00f6v J, Gasparini A, et al. Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality. Kidney Int. 2017;91(1):244\u201351. https:\/\/doi.org\/10.1016\/j.kint.2016.09.037.","journal-title":"Kidney Int"},{"issue":"4","key":"5339_CR20","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M23-2814","volume":"177","author":"A Verma","year":"2024","unstructured":"Verma A, Schmidt IM, Claudel S, Palsson R, Waikar SS, Srivastava A. Association of Albuminuria With Chronic Kidney Disease Progression in Persons With Chronic Kidney Disease and Normoalbuminuria: A Cohort Study. Ann Intern Med. 2024;177(4):467\u201375. https:\/\/doi.org\/10.7326\/M23-2814.","journal-title":"Ann Intern Med"},{"issue":"13","key":"5339_CR21","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1001\/jama.2023.17002","volume":"330","author":"ME Grams","year":"2023","unstructured":"Writing Group for the CKD Prognosis Consortium, Grams ME, Coresh J, Matsushita K, Ballew SH, Sang Y, et al. Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis. JAMA. 2023;330(13):1266\u201377. https:\/\/doi.org\/10.1001\/jama.2023.17002.","journal-title":"JAMA"},{"key":"5339_CR22","unstructured":"Sa\u00fade Mda. Brazil. Rela\u00e7\u00e3o Nacional de Medicamentos Especiais (RENAME), 2024. Available from: https:\/\/www.gov.br\/saude\/pt-br\/composicao\/sectics\/rename\/rename-2024."},{"key":"5339_CR23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jclinepi.2019.12.020","volume":"122","author":"HJ Sch\u00fcnemann","year":"2020","unstructured":"Sch\u00fcnemann HJ, Mustafa RA, Brozek J, Steingart KR, Leeflang M, GRADE Working Group, et al. GRADE guidelines: 21 part 1. Study design, risk of bias, and indirectness in rating the certainty across a body of evidence for test accuracy. J Clin Epidemiol. 2020;122:129\u201341. https:\/\/doi.org\/10.1016\/j.jclinepi.2019.12.020.","journal-title":"J Clin Epidemiol"},{"key":"5339_CR24","unstructured":"Sa\u00fade Minist\u00e9rioda. Brasil. Departamento de Inform\u00e1tica do Sistema \u00danico de Sa\u00fade, DATASUS. Sistema de Gerenciamento da Tabela de Procedimentos, Medicamentos e OPM (\u00d3rteses, pr\u00f3teses e materiais) do SUS (SIGTAP). Available from: http:\/\/sigtap.datasus.gov.br\/tabela-unificada\/app\/sec\/inicio.jsp."},{"issue":"1","key":"5339_CR25","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12882-024-03597-9","volume":"25","author":"F Samaan","year":"2024","unstructured":"Samaan F, Silveira RC, Mouro A, Kirsztajn GM, Sesso R. Laboratory-based surveillance of chronic kidney disease in people with private health coverage in Brazil. BMC Nephrol. 2024;25(1):162. https:\/\/doi.org\/10.1186\/s12882-024-03597-9.","journal-title":"BMC Nephrol"},{"key":"5339_CR26","unstructured":"Minist\u00e9rio da Sa\u00fade. Brazil. Ag\u00eancia Nacional de Sa\u00fade Suplementar. Informa\u00e7\u00f5es em sa\u00fade complementar: taxa de cobertura de planos de sa\u00fade. Available from: http:\/\/www.ans.gov.br\/anstabnet\/cgi-bin\/dh?dados\/tabnet_tx.def"},{"issue":"2","key":"5339_CR27","doi-asserted-by":"publisher","first-page":"e20250144","DOI":"10.1590\/2175-8239-JBN-2025-0144en","volume":"48","author":"F Samaan","year":"2026","unstructured":"Samaan F, Suh LH, Freire SDL, Sesso R, Kirsztajn GM. Coverage of procedures related to chronic kidney disease care in the Brazilian Unified Health System (SUS): analysis of the 2015\u20132024 decade. J Bras Nefrol. 2026;48(2):e20250144. https:\/\/doi.org\/10.1590\/2175-8239-JBN-2025-0144en.","journal-title":"J Bras Nefrol"},{"issue":"2","key":"5339_CR28","doi-asserted-by":"publisher","first-page":"e00090821","DOI":"10.1590\/0102-311X00090821","volume":"38","author":"F Samaan","year":"2022","unstructured":"Samaan F, Fernandes DE, Kirsztajn GM, Sesso RCC, Malik AM. Quality indicators for primary health care in chronic kidney disease in the public service of a city in the State of S\u00e3o Paulo, Brazil. Cad Saude Publica. 2022;38(2):e00090821. https:\/\/doi.org\/10.1590\/0102-311X00090821.","journal-title":"Cad Saude Publica"},{"issue":"9","key":"5339_CR29","doi-asserted-by":"publisher","first-page":"e102044","DOI":"10.1136\/bmjopen-2025-102044","volume":"15","author":"DB Ketema","year":"2025","unstructured":"Ketema DB, Wallace H, Hailu W, Badve SV, Ronksley P, et al. Quality of care for people with chronic kidney disease: a systematic review and meta-analysis. BMJ Open. 2025;15(9):e102044. https:\/\/doi.org\/10.1136\/bmjopen-2025-102044.","journal-title":"BMJ Open"},{"issue":"1","key":"5339_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.kisu.2024.01.001","volume":"13","author":"V Calice-Silva","year":"2024","unstructured":"Calice-Silva V, Neyra JA, Ferreiro Fuentes A, Singer Wallbach Massai KK, Arruebo S, Bello AK, Regional Board and ISN-GKHA Team Authors. Capacity for the management of kidney failure in the International Society of Nephrology Latin America region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA). Kidney Int Suppl (2011). 2024;13(1):43\u201356. https:\/\/doi.org\/10.1016\/j.kisu.2024.01.001.","journal-title":"Kidney Int Suppl (2011)"},{"issue":"3","key":"5339_CR31","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1590\/1516-3180.2021.0194.R1.13082021","volume":"140","author":"F Samaan","year":"2022","unstructured":"Samaan F, Fernandes DE, Kirsztajn GM, Sesso R. The first appointment with a nephrologist: Brazilian patients\u2019 demographic and kidney function characteristics. A retrospective study. Sao Paulo Med J. 2022;140(3):366\u201371. https:\/\/doi.org\/10.1590\/1516-3180.2021.0194.R1.13082021.","journal-title":"Sao Paulo Med J"},{"key":"5339_CR32","doi-asserted-by":"publisher","unstructured":"Samaan F, Clemente \u00c1MI, Zaicaner R, Kirsztajn GM, Sesso R. Registry of access to chronic dialysis initiation at the public health system in Brazil. Int Urol Nephrol. 2025 Jul;14. https:\/\/doi.org\/10.1007\/s11255-025-04652-6.","DOI":"10.1007\/s11255-025-04652-6"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-05339-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05339-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05339-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:32:28Z","timestamp":1791545548000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-05339-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5339"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-05339-5","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"assertion":[{"value":"7 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Hapvida Research Ethics Committee under certificate number 79748524.4.0000.0229. The requirement for written informed consent was waived by the Research Ethics Committee because the study involved only analysis of laboratory methods and did not expose participants to physical or biological risks.","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"599"}}